Perspect Biol Med:贝多芬的音乐创作或受其心律失常影响

2015-01-14 国际循环 Perspect Biol Med

一项对贝多芬的音乐研究发现,这一伟大的作曲家可能患有心律不齐或心律失常,因为研究者从他的一些作品中可听到他们描述的音乐性心律失常。这一惊人发现来自一个包含密歇根大学和西雅图华盛顿大学的医学史学家、心脏病学家和音乐家的研究小组。研究发表在Perspectives in Biology and Medicine。 200年前,贝多芬完成了他的伟大音乐作品,但关于其健康和困苦的令人信服的证据很

一项对贝多芬的音乐研究发现,这一伟大的作曲家可能患有心律不齐或心律失常,因为研究者从他的一些作品中可听到他们描述的音乐性心律失常。这一惊人发现来自一个包含密歇根大学和西雅图华盛顿大学的医学史学家、心脏病学家和音乐家的研究小组。研究发表在Perspectives in Biology and Medicine。

200年前,贝多芬完成了他的伟大音乐作品,但关于其健康和困苦的令人信服的证据很少。他经常被描述的疾病是耳聋,本研究的研究者认为这可能加剧了他对心跳的感知度,使得这位伟人通过遵从自己的心脏创作出音乐。

另有理论指出,贝多芬也有其他健康问题,包括肝病、酗酒、肾病、炎症性肠病和异常骨破坏或Paget病。第一作者华盛顿大学医学院Zachary D. Goldberger讲到,“由于当代的几乎所有医学检测方法在18世纪都不存在,因此我们不能证实或反驳贝多芬曾遭受以上推断的很多疾病,我们目前正在试图解释这种持续了几个世纪的医学描述。”

音乐心电图”揭示贝多芬作品中的心律失常模式

在这项研究中,研究团队检测了贝多芬一些作品中的节奏,发现了其与现代心律失常检测设备相似的“音乐心电图”匹配。研究者称,突然、意想不到的速度和节奏变化似乎与不规则心跳的不对称模式匹配——太快(心动过速)、太慢(心动过缓)或不规律(颤动)。例如,他们研究的其中一个作品是贝多芬的降B大调弦乐四重奏Op.130“短抒情调”最后乐章,贝多芬讲到这部分曾使他哭泣。在短抒情调的中间部分,突然变调至降C大调。与节奏的不平衡一起,这种突然变化唤起了一种忧郁的情绪和方向迷失,被描述为类似“呼吸急促”。作者指出,“这部分的心律不齐特征毫无疑问”。

“沉重的心”是否意味着贝多芬感到心脏压力很大

在演奏这部分时,贝多芬使用了德语单词“beklemmt”表示“沉重的心”。研究者指出,“沉重的心”可意味着悲伤,更书面的意思为压力感,后者与心脏疾病有关。研究团队也发现贝多芬其他作品中的心律失常模式,如降A大调钢琴奏鸣曲Op.110和降E大调离别奏鸣曲Op.81a的开头,这些作品是贝多芬在1809年拿破仑进攻期间完成。

Goldberger评论,“虽然这些音乐性心律失常可能仅反映了贝多芬的天赋,但有可能在某些作品中,他的心脏节律成就了其最伟大的作品。”

原始出处:

Goldberger ZD, Whiting SM, Howell JD.The heartfelt music of ludwig van beethoven.Perspect Biol Med. 2014;57(2):285-94. doi: 10.1353/pbm.2014.0013.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1917119, encodeId=f6f6191e11940, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Oct 04 17:21:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956186, encodeId=17e4195618683, content=<a href='/topic/show?id=2e16922211e' target=_blank style='color:#2F92EE;'>#贝多芬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92221, encryptionId=2e16922211e, topicName=贝多芬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89da2500024, createdName=1194695146_61857347, createdTime=Sun Mar 22 10:21:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878089, encodeId=fadf18e808940, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 13 18:21:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766923, encodeId=e77b1e66923e9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Dec 06 23:21:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725726, encodeId=24001e2572659, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 06 07:21:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426141, encodeId=262e142614188, content=<a href='/topic/show?id=47db100050b7' target=_blank style='color:#2F92EE;'>#音乐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100050, encryptionId=47db100050b7, topicName=音乐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76b14038458, createdName=weiz, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606372, encodeId=5ce116063e2f8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=)]
    2015-10-04 sunylz
  2. [GetPortalCommentsPageByObjectIdResponse(id=1917119, encodeId=f6f6191e11940, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Oct 04 17:21:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956186, encodeId=17e4195618683, content=<a href='/topic/show?id=2e16922211e' target=_blank style='color:#2F92EE;'>#贝多芬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92221, encryptionId=2e16922211e, topicName=贝多芬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89da2500024, createdName=1194695146_61857347, createdTime=Sun Mar 22 10:21:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878089, encodeId=fadf18e808940, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 13 18:21:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766923, encodeId=e77b1e66923e9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Dec 06 23:21:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725726, encodeId=24001e2572659, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 06 07:21:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426141, encodeId=262e142614188, content=<a href='/topic/show?id=47db100050b7' target=_blank style='color:#2F92EE;'>#音乐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100050, encryptionId=47db100050b7, topicName=音乐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76b14038458, createdName=weiz, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606372, encodeId=5ce116063e2f8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1917119, encodeId=f6f6191e11940, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Oct 04 17:21:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956186, encodeId=17e4195618683, content=<a href='/topic/show?id=2e16922211e' target=_blank style='color:#2F92EE;'>#贝多芬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92221, encryptionId=2e16922211e, topicName=贝多芬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89da2500024, createdName=1194695146_61857347, createdTime=Sun Mar 22 10:21:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878089, encodeId=fadf18e808940, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 13 18:21:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766923, encodeId=e77b1e66923e9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Dec 06 23:21:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725726, encodeId=24001e2572659, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 06 07:21:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426141, encodeId=262e142614188, content=<a href='/topic/show?id=47db100050b7' target=_blank style='color:#2F92EE;'>#音乐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100050, encryptionId=47db100050b7, topicName=音乐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76b14038458, createdName=weiz, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606372, encodeId=5ce116063e2f8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=)]
    2015-04-13 anminleiryan
  4. [GetPortalCommentsPageByObjectIdResponse(id=1917119, encodeId=f6f6191e11940, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Oct 04 17:21:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956186, encodeId=17e4195618683, content=<a href='/topic/show?id=2e16922211e' target=_blank style='color:#2F92EE;'>#贝多芬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92221, encryptionId=2e16922211e, topicName=贝多芬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89da2500024, createdName=1194695146_61857347, createdTime=Sun Mar 22 10:21:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878089, encodeId=fadf18e808940, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 13 18:21:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766923, encodeId=e77b1e66923e9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Dec 06 23:21:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725726, encodeId=24001e2572659, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 06 07:21:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426141, encodeId=262e142614188, content=<a href='/topic/show?id=47db100050b7' target=_blank style='color:#2F92EE;'>#音乐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100050, encryptionId=47db100050b7, topicName=音乐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76b14038458, createdName=weiz, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606372, encodeId=5ce116063e2f8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1917119, encodeId=f6f6191e11940, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Oct 04 17:21:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956186, encodeId=17e4195618683, content=<a href='/topic/show?id=2e16922211e' target=_blank style='color:#2F92EE;'>#贝多芬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92221, encryptionId=2e16922211e, topicName=贝多芬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89da2500024, createdName=1194695146_61857347, createdTime=Sun Mar 22 10:21:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878089, encodeId=fadf18e808940, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 13 18:21:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766923, encodeId=e77b1e66923e9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Dec 06 23:21:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725726, encodeId=24001e2572659, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 06 07:21:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426141, encodeId=262e142614188, content=<a href='/topic/show?id=47db100050b7' target=_blank style='color:#2F92EE;'>#音乐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100050, encryptionId=47db100050b7, topicName=音乐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76b14038458, createdName=weiz, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606372, encodeId=5ce116063e2f8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=)]
    2015-04-06 feather89
  6. [GetPortalCommentsPageByObjectIdResponse(id=1917119, encodeId=f6f6191e11940, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Oct 04 17:21:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956186, encodeId=17e4195618683, content=<a href='/topic/show?id=2e16922211e' target=_blank style='color:#2F92EE;'>#贝多芬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92221, encryptionId=2e16922211e, topicName=贝多芬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89da2500024, createdName=1194695146_61857347, createdTime=Sun Mar 22 10:21:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878089, encodeId=fadf18e808940, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 13 18:21:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766923, encodeId=e77b1e66923e9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Dec 06 23:21:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725726, encodeId=24001e2572659, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 06 07:21:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426141, encodeId=262e142614188, content=<a href='/topic/show?id=47db100050b7' target=_blank style='color:#2F92EE;'>#音乐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100050, encryptionId=47db100050b7, topicName=音乐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76b14038458, createdName=weiz, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606372, encodeId=5ce116063e2f8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=)]
    2015-01-16 weiz
  7. [GetPortalCommentsPageByObjectIdResponse(id=1917119, encodeId=f6f6191e11940, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sun Oct 04 17:21:00 CST 2015, time=2015-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1956186, encodeId=17e4195618683, content=<a href='/topic/show?id=2e16922211e' target=_blank style='color:#2F92EE;'>#贝多芬#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92221, encryptionId=2e16922211e, topicName=贝多芬)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=89da2500024, createdName=1194695146_61857347, createdTime=Sun Mar 22 10:21:00 CST 2015, time=2015-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1878089, encodeId=fadf18e808940, content=<a href='/topic/show?id=c157696175' target=_blank style='color:#2F92EE;'>#ERS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6961, encryptionId=c157696175, topicName=ERS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e93e105, createdName=anminleiryan, createdTime=Mon Apr 13 18:21:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1766923, encodeId=e77b1e66923e9, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Dec 06 23:21:00 CST 2015, time=2015-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725726, encodeId=24001e2572659, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Mon Apr 06 07:21:00 CST 2015, time=2015-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1426141, encodeId=262e142614188, content=<a href='/topic/show?id=47db100050b7' target=_blank style='color:#2F92EE;'>#音乐#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100050, encryptionId=47db100050b7, topicName=音乐)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=76b14038458, createdName=weiz, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606372, encodeId=5ce116063e2f8, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Jan 16 00:21:00 CST 2015, time=2015-01-16, status=1, ipAttribution=)]

相关资讯

OCC 2014:戚文航教授谈心衰患者中心律失常的治疗

东方心脏病学会议(OCC2014)上,上海瑞金医院戚文航教授介绍了心衰患者中心律失常的药物治疗方法。 上海瑞金医院戚文航教授 心律失常抑制与生存率、死亡率的矛盾关系 CAPS、CAST、CASTⅡ、IMPACT等临床研究显示,在缺血性心律失常治疗中,Ⅰ类抗心律失常药物可显著抑制心律失常,但死亡率显著增加,这种现象同样见于心力衰竭、心肌病的心律失常治疗中。心律失常与心力衰竭互为因果

ESC 2014:室性心律失常专家共识要点

2014年8月30日西班牙巴塞罗那—— 《EHRA/HRS/APHRS心律失常专家共识》今天在线发表于EP Europace上。这份共识由ESC所属欧洲心脏节律学会(EHRA)、心脏节律学会(HRS)和亚太心脏节律协会(APHRS)联合发表,是关于室性心律失常的第一份专家共识。 共识联合主席丹麦Christian Torp-Pedersen教授指出,这份共识的推荐得到欧洲、美国和亚洲三大学会的一

HRS心脏结节病相关心律失常的诊断和治疗专家共识

在美国心律学会年会(HRS 2014)召开之际,《心律学》(Heart Rhythm)杂志于5月9日在线发表了《心脏结节病相关心律失常的诊断和治疗HRS专家共识》。 指南下载:心脏结节病相关心律失常的诊断和治疗HRS 原始出处:David H. Birnie,William H. Sauer, Frank Bogun,Joshua M. Cooper,Daniel A. Culver,Clai

HRS 2014:美国心律学会共识5连发

2014年5月7-9日,在美国心律学会(HRS)年会期间,HRS接连在《心律》(Heart Rhythm)杂志发布五部共识文件,为广大心律医生奉上了一场“共识盛宴”。 《HRS/美国心脏病学会(ACC)/美国心脏学会(AHA)关于在临床试验未纳入或不典型患者中ICD应用的共识声明》还同时在线发表于《循环》(Circulation)。该共识主要关注以下可能自ICD获益的人群:非心肌梗死导致的肌钙蛋

PACES/HRS心脏结构正常儿童的室性心律失常的评估和管理专家共识声明

在美国心律学会年会(HRS 2014)召开之际,《心律学》(Heart Rhythm)杂志于5月8日在线发表了《PACES/HRS心脏结构正常儿童的室性心律失常的评估和管理专家共识声明》。 该指南目的是为了给心脏结构正常的儿童发生室性心律失常时,给予最新的评估和治疗推荐。 附图: 下载共识:PACES/HRS心脏结构正常儿童的室性心律失常的评估和管理专家共识声

PACES/HRS先心病成人心律失常认识和管理专家共识

在美国心律学会年会(HRS 2014)召开之际,《心律学》(Heart Rhythm)杂志于5月8日在线发表了《PACES/HRS先天性心脏病成人心律失常的认识和管理专家共识》。指南下载:PACES/HRS先心病成人心律失常认识和管理专家共识 原始出处:Paul Khairy, George F Van Hare, Seshadri Balaji, Charles I Berul, Frank C